Injectable Drugs 2021


Competition among the various drug and therapeutic classes is uneven, with the top ten segments accounting for a disproportionate level of activity and revenue. Understanding the underlying factors affecting business performance is key to attaining financial targets. Provider organization business managers, healthcare administrators and investors will also benefit from this study.



This report is a comprehensive evaluation and analysis of the products and participants in this evolving segment of the injectable drug sector. It is designed to provide drug product decision makers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, disease segments, and commercial opportunities for injectables. These products are marketed and supplied by slightly less than one hundred companies.